Japan's Mitsubishi Pharma Corporation Loses Patent Bid over Diabetes Drug “Teneligliptin” - 14.12.2015

Kolkata Patent Office on an opposition filed by domestic drug firm Lupin, refused the patent application filed by Japan's Mitsubishi Pharma Corporation claiming monopoly rights on a new diabetes drug, teneligliptin, on grounds that it was "obvious, and lacking inventive step".

Tags : Kolkata Patent Office Patent Diabetes Drug Teneligliptin

Share :